Leveraging an
agreement with a leading European sensor developer, Zenosense is developing a
novel device that detects Methicillin-resistant Staphylococcus Aureus (MRSA)
bacterial contamination, commonly referred to as “staph.” The company intends
to market the developed product primarily to hospitals to combat
healthcare-associated infections (HAIs).
The Centers for
Disease Control and Prevention (CDC) estimate that one in every 20 patients
treated in U.S. hospitals develop an HAI, which are directly responsible for at
least 23,000 deaths per year in the United States alone.
Industry figures
estimate the annual costs of treating hospitalized MRSA patients specifically
to be between $3.2 billion and $4.2 billion in the United States alone.
Infected patients are likely to spend three times as long in a hospital stay at
three times the cost, and are five times more likely to die than an uninfected
patient.
The Zenosense MRSA
detection device, which is being exclusively developed by Sgenia Group through
their subsidiary Zenon Biosystem, is designed to function like a “smoke
detector” for MRSA. The device is expected to detect MRSA in the environment,
such as a hospital setting, or infected patient, even before a patient
demonstrates any obvious symptoms.
Utilizing
established Sgenia programming and patent-pending hardware, the Zenosense
detector utilizes a single sensor to perform an infinite number of scans,
creating tens of thousands of “virtual sensors.”
Upon final product
development, the Zenosense device may be worn by individuals, as well as placed
in numerous sensitive areas in the healthcare setting, addressing this dire
unmet medical need. Recent studies suggest that implementing prevention
practices can slash occurrence of HAIs by an astounding 70%, saving between
$25.0 billion and $31.5 billion in medical cost savings in the United States.
For more information
visit www.zenosense.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment